Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled study

Fig. 4

a Mean difference of DAD score by MMSE score and memantine. Two sites (049134 and 049137) excluded from the analysis due to GCP noncompliance. b Mean difference of DAD score by median age and memantine. Two sites (049134 and 049137) excluded from the analysis due to GCP noncompliance. Median DAD score = 62.16. c Mean difference of DAD score by DAD score and memantine. DAD Disability Assessment for Dementia, diff difference, MMSE Mini-Mental State Examination, lcl lower confidence limit, ucl upper confidence limit

Back to article page